GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
42.57
+1.13 (2.73%)
At close: May 1, 2024, 4:00 PM
42.54
-0.04 (-0.08%)
After-hours: May 1, 2024, 7:41 PM EDT
GSK Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$46.00
Upside
+8.06%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 4, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $44 | Hold | Initiates | $44 | +3.36% | Jan 23, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $39 → $48 | Hold → Strong Buy | Upgrades | $39 → $48 | +12.76% | Jan 3, 2024 |
DZ Bank | DZ Bank | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 11, 2022 |
Barclays | Barclays | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Nov 5, 2021 |
SVB Leerink | SVB Leerink | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 23, 2021 |
Deutsche Bank | Deutsche Bank | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Feb 4, 2021 |
Deutsche Bank | Deutsche Bank | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jan 15, 2021 |
Argus Research | Argus Research | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 20, 2018 |
Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 5, 2017 |